Evaluation of the efficacy of Pentoxiphyllin in hospitalized diabetic patients with covid19

Phase 3

• Conditions: covid 19.; U09; Post-COVID

• Registration Number: IRCT20230523058271N1
• Lead Sponsor: Yazd University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 16 October 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Diagnosis of covid in the last 24 to 48 hours
Candidate for hospitalization (o2sat<93% or RR>24 or Pao2/Fio2<300)
Covid-19 patients who are candidates for hospitalization with indications for hospitalization according to the country's guidelines, who had pulmonary infiltration in CT scan
Outpatients with pulmonary infiltration on CT scan
Age 18 to 70 years

Exclusion Criteria

Patients who were treated with Coltera (lupinavir/ritonavir).
Patients with shock or hemodynamic instability
Drug intolerance
Patients with a history of Crohn's or ulcerative colitis, diarrhea or chronic malabsorption
Neuromuscular diseases
GFR less than 30 ml/min
History of cirrhosis, hepatitis and severe liver diseases
Patients receiving chemotherapy for cancer
Pregnancy and breastfeeding

Study & Design

• Study Type: interventional
• Study Design: Not specified